Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
Innate Pharma (IPHA)
- 1.830
- +0.090+5.17%
Close May 29 16:00 ET
- 1.833
- +0.003+0.15%
Post 20:01 ET
171.84MMarket Cap-2.85P/E (TTM)
1.920High1.830Low10.60KVolume1.880Open1.740Prev Close19.81KTurnover0.02%Turnover RatioLossP/E (Static)93.90MShares2.63052wk High-6.80P/B120.80MFloat Cap1.17052wk Low--Dividend TTM66.01MShs Float11.950Historical High--Div Yield TTM5.17%Range %1.170Historical Low1.868Avg Price1Lot Size
Innate Pharma (IPHA) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -372.14%-32.56M | 86.93%-6.9M | -175.41%-52.76M | 67.23%-19.16M | -12.92%-58.46M | -248.23%-51.77M | 207.36%34.93M | 32.32%-32.53M | -30.43%-48.06M | -118.28%-36.85M |
| Net income from continuing operations | 84.70%-7.57M | -0.60%-49.47M | 15.36%-49.18M | -10.02%-58.1M | 17.47%-52.81M | -208.22%-63.98M | -780.85%-20.76M | 106.30%3.05M | -482.79%-48.39M | 288.49%12.64M |
| Operating gains losses | 156.93%308K | -193.60%-541K | 205.67%578K | 48.69%-547K | -309.02%-1.07M | 157.63%510K | 61.67%-885K | -161.38%-2.31M | 295.53%3.76M | -228.33%-1.92M |
| Depreciation and amortization | 155.32%5.09M | 44.08%1.99M | -96.95%1.38M | 887.92%45.41M | -91.91%4.6M | 243.62%56.8M | 123.33%16.53M | 68.47%7.4M | 34.63%4.39M | 22.90%3.26M |
| Other non cash items | 101.69%6K | -0.56%-356K | -366.17%-354K | 114.35%133K | -301.52%-927K | -10.85%460K | 102.35%516K | 116.67%255K | -299.48%-1.53M | -897.92%-383K |
| Change In working capital | -181.95%-32.09M | 468.34%39.16M | 14.96%-10.63M | -26.48%-12.5M | 79.91%-9.89M | -222.26%-49.21M | 185.46%40.25M | -177.36%-47.1M | 66.57%-16.98M | -124.75%-50.79M |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -163.38%-16.17M |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.89M |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -120.39%-42.5M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -372.14%-32.56M | 86.93%-6.9M | -175.41%-52.76M | 67.23%-19.16M | -12.92%-58.46M | -248.23%-51.77M | 207.36%34.92M | 32.32%-32.53M | -30.42%-48.06M | -118.28%-36.85M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 124.26%20.63M | 26.22%9.2M | 288.28%7.29M | 304.69%1.88M | 93.14%-917K | 78.48%-13.37M | -355.85%-62.12M | 180.23%24.28M | -150.01%-30.26M | 152.18%60.51M |
| Net PPE purchase and sale | 48.59%-201K | -179.29%-391K | 73.83%-140K | 41.97%-535K | -2.67%-922K | 29.35%-898K | -45.59%-1.27M | 70.04%-873K | -115.85%-2.91M | -25.93%-1.35M |
| Net intangibles purchase and sale | ---2M | --0 | --0 | -46.38%-587K | 96.13%-401K | 83.82%-10.38M | -11,434.17%-64.13M | 81.84%-556K | 61.93%-3.06M | ---8.04M |
| Net investment purchase and sale | 137.41%22.77M | 36.32%9.59M | 134.50%7.04M | --3M | --0 | -250.00%-3M | -91.74%2M | 194.12%24.22M | -136.81%-25.73M | 160.84%69.9M |
| Net other investing changes | 6,200.00%63K | -83.33%1K | 700.00%6K | -102.56%-1K | 166.10%39K | -490.00%-59K | -121.74%-10K | -94.28%46K | --804K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 124.24%20.63M | 26.22%9.2M | 288.33%7.29M | 304.69%1.88M | 93.14%-917K | 78.48%-13.37M | -355.86%-62.12M | 182.41%24.28M | -148.69%-29.46M | 152.18%60.51M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 67.28%-1.97M | -198.98%-6.01M | 432.06%6.07M | -106.82%-1.83M | 2,376.57%26.82M | -101.51%-1.18M | 27.02%77.76M | 6,591.04%61.22M | 251.99%915K | -119.86%-602K |
| Net issuance payments of debt | 73.58%-2.36M | -0.28%-8.94M | -339.83%-8.91M | -107.61%-2.03M | 3,109.15%26.63M | -107.43%-885K | 987.42%11.92M | -350.09%-1.34M | 178.39%537K | -51.55%-685K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | 5.51%66.01M | --62.56M | ---- | -88.80%14K |
| Cash dividends paid | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -86.51%395K | -80.46%2.93M | 7,466.16%14.98M | -60.32%198K | 939.58%499K | 9.09%48K | -60.36%44K | -77.39%111K | 154.40%491K | -94.48%193K |
| Net other financing activities | ---- | ---- | ---- | ---- | 0.00%1K | 0.00%1K | 200.00%1K | ---1K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 67.28%-1.97M | -198.98%-6.01M | 432.06%6.07M | -106.82%-1.83M | 2,378.59%26.82M | -101.51%-1.18M | 27.02%77.77M | 6,590.93%61.22M | 251.99%915K | -119.85%-602K |
| Net cash flow | ||||||||||
| Beginning cash position | 19.29%84.23M | 6.34%70.61M | -36.01%66.4M | -24.15%103.76M | -32.58%136.79M | 33.20%202.89M | 53.28%152.31M | -43.51%99.37M | 15.07%175.91M | 137.80%152.87M |
| Current changes in cash | -275.11%-13.89M | 90.60%-3.7M | -106.23%-39.4M | 41.32%-19.1M | 50.91%-32.55M | -231.14%-66.31M | -4.54%50.57M | 169.15%52.97M | -432.21%-76.61M | -73.99%23.06M |
| Effect of exchange rate changes | 154.26%274K | -146.25%-505K | 355.14%1.09M | 11.39%-428K | -320.55%-483K | 4,280.00%219K | 119.23%5K | -139.39%-26K | 386.96%66K | 63.49%-23K |
| End cash Position | 6.34%70.61M | 136.35%66.4M | -66.65%28.09M | -18.82%84.23M | -24.15%103.76M | -32.58%136.79M | 33.20%202.89M | 53.28%152.31M | -43.51%99.37M | 15.07%175.91M |
| Free cash flow | -379.07%-34.91M | 86.22%-7.29M | -160.86%-52.9M | 66.08%-20.28M | 5.17%-59.79M | -106.87%-63.05M | 10.25%-30.48M | 37.21%-33.96M | -16.96%-54.09M | -123.06%-46.24M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | -- |
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 29, Eastern Time, Trump held a two-hour meeting in the White House Situation Room but has not yet reached a final decision on negotia
Futubull Options Sir
May 26 18:03
Options Sir on Macro | Big Week Ahead! US-Iran Deal May Materialize + PCE Data Looms—How to Navigate Markets Next?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.